Ricinoleic Acid Lauryl Ester | 93980-68-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Ricinoleic Acid Lauryl Ester
• 英文别名: Dodecyl ricinoleate；dodecyl (Z,12R)-12-hydroxyoctadec-9-enoate
• CAS: 93980-68-8
• 化学式: C₃₀H₅₈O₃
• 分子量: 466.789
• InChiKey: RAPSKERQUJHWAM-HYTUOHKXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  11.6
• 重原子数：
  33
• 可旋转键数：
  27
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  蓖麻油酸 、 十二烷醇 在 对甲苯磺酸 作用下， 生成 Ricinoleic Acid Lauryl Ester
  参考文献：
  名称：

  CN116041229

  摘要：

  公开号：

文献信息

• FUNCTIONALIZED MONOMERS AND POLYMERS
  申请人：DiBiase Stephen Augustine

  公开号：US20120245063A1

  公开（公告）日：2012-09-27

  This invention relates to a composition, comprising: an unsaturated functionalized monomer of from about 5 to about 30 carbon atoms, which is: (a) polymerized to form a functionalized polymer; (b) copolymerized with a comonomer to form a functionalized copolymer; or (c) reacted with an enophilic reagent to form a polyfunctionalized monomer. The polyfunctionalized monomer may be polymerized to form a polyfunctionalized polymer which may be further reacted with one or more additional reagents. The invention relates to lubricants, functional fluids, fuels, dispersants, detergents and polymeric resins.

  这项发明涉及一种组合物，包括：一个由约5至约30个碳原子的不饱和官能化单体组成，该单体：(a)聚合形成官能化聚合物；(b)与共聚单体共聚形成官能化共聚物；或(c)与亲亚烯试剂反应形成多官能单体。多官能单体可以聚合形成多官能聚合物，该聚合物可以进一步与一个或多个额外试剂反应。该发明涉及润滑剂、功能流体、燃料、分散剂、清洁剂和聚合树脂。
• Polymeric formulations for drug delivery
  申请人：Efrat Biopolymers Ltd.

  公开号：US20040161464A1

  公开（公告）日：2004-08-19

  Poly(ester-anhydrides) or polyesters formed from ricinoleic acid and natural fatty diacids and their method of preparation and its use for delivering bioactive agents including small drug molecules, peptides and proteins, DNA and DNA complexes with cationic lipids or polymers or nano and microparticles loaded with bioactive agents are disclosed herein. The drug delivery compositions are administered to a patient in a liquid form, increase in viscosity in vivo to form a drug depot or implant, and are able to release the incorporated bioactive agent for weeks. In the preferred embodiment, the drug delivery formulations are administered by injection. In one embodiment, the compositions are suitable for local or regional delivery of drugs to diseased sites, such as treating solid tumors and bone infections. In a preferred embodiment, the drug delivery compositions are suitable for site-specific chemotherapy for the treatment of solid tumors including: squamous cell carcinoma (SCC) of the head and neck, prostate cancer, and sarcomas for intratumoral injection or insertion.

  本文公开了由蓖麻油酸和天然脂肪二酸形成的聚酯酸酐或聚酯以及它们的制备方法，以及它们用于输送生物活性剂，包括小分子药物、肽和蛋白质、DNA和带阳离子脂质或聚合物或纳米和微粒子的DNA复合物。这些药物输送组合物以液态形式给患者使用，在体内粘度增加形成药物库或植入物，并能够持续释放所包含的生物活性剂达数周之久。在首选实施例中，药物输送配方通过注射给予。在一个实施例中，该组合物适用于将药物局部或区域性输送到疾病部位，例如治疗实体肿瘤和骨感染。在首选实施例中，药物输送组合物适用于针对实体肿瘤的特定部位化疗，包括头颈鳞状细胞癌（SCC）、前列腺癌和肉瘤的肿瘤内注射或插入。
• Polyanhydrides
  申请人：——

  公开号：US20040057970A1

  公开（公告）日：2004-03-25

  The invention provides polyanhydrides with aliphatic hydrocarbon terminals having ester or amide bonds.

  该发明提供了具有酯或酰胺键的脂肪族碳末端的聚酸酐。
• SYNERGISTIC LUBRICATING OIL COMPOSITION CONTAINING A MIXTURE OF A NITRO-SUBSTITUTED DIARYLAMINE AND A DAIRYLAMINE
  申请人：Cherpeck Richard E.

  公开号：US20080318815A1

  公开（公告）日：2008-12-25

  Disclosed is a lubricating oil composition containing an oil of lubricating viscosity and a particularly effective mixture of a nitro-substituted diphenylamine and a diarylamine which together provide superior oxidation inhibition.

  公开了一种润滑油组合物，包含具有润滑粘度的油和一种特别有效的硝基取代二苯胺和二芳胺混合物，二者共同提供卓越的氧化抑制作用。
• Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine
  申请人：Cherpeck E. Richard

  公开号：US20070142243A1

  公开（公告）日：2007-06-21

  Disclosed is a lubricating oil composition containing an oil of lubricating viscosity and a particularly effective mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine which together provide superior oxidation inhibition.

  揭示了一种润滑油组合物，其中包含具有润滑粘度的油和一种特别有效的苯并[b]过氢杂环芳胺和二芳基胺的混合物，两者共同提供卓越的氧化抑制作用。